In this prospective cohort of incident HD patients with preserved or mildly reduced LVEF (≥40%), elevated serum galectin-3 levels were independently associated with an increased risk of the primary composite outcome, CV death or acute HF hospitalization, as well as all-cause mortality. Here, LGALS3 is linked to Huntington disease.